Home Tags Johnson & Johnson

Johnson & Johnson

Bristol Myers’ stock decline in response to weak guidance is a gift to investors

Bristol Myers’ stock decline in response to weak guidance is a...

kinect-news.com -

Stocks close higher, S&P 500 touches fresh record, bolstered by Trump...

kinect-news.com -

Healthy Returns: Biotech and pharma M&A is off to a good...

kinect-news.com -

FDA approves Johnson & Johnson’s nasal spray for depression as standalone...

kinect-news.com -

Healthy Returns: From Eli Lilly to Amazon, here are the latest...

kinect-news.com -

J&J says its lung cancer drug combination keeps people alive longer

kinect-news.com -

These innovative biotech stocks have a good chance of breaking out...

kinect-news.com -

SpaceX valuation surges to $350 billion as company buys back stock

kinect-news.com -

FDA proposes ending use of decongestant found in many cold, allergy...

kinect-news.com -

Nvidia, Google, Microsoft and more head to Las Vegas to tout...

kinect-news.com -
©
Exit mobile version